This German study found that free iron induces ferroptosis, a specific type of cell death in human brain pericytes, contributing to blood–brain barrier dysfunction, disruption of vascular continuity, and vasoconstriction. Intraparenchymal hemorrhage accounts for approximately 8-13% of all strokes. It is more likely to result in death or major disability than ischemic stroke or subarachnoid hemorrhage,
I would think that ATH434 could have a role in preventing ferroptosis in these cases, but more research is needed.Intracerebral Hemorrhage-Associated Iron Release Leads to Pericyte-Dependent Cerebral Capillary Function Disruption
AffiliationsPMCID: PMC11852616 DOI: 10.3390/biom15020164
- PMID: 40001467
Abstract
Intracerebral hemorrhage leads to immediate brain injury due to local mechanical damage, on which current treatment approaches are focused, but it also induces secondary brain injury. The purpose of this study is to characterize blood components, degradation products and their effects in secondary brain injury. Immunocyto- and immunohistochemistry, Fluorescence-Activated Cell Sorting, WST-1 assays and RNA sequencing were applied using human cell cultures and human ex vivo brain tissue slices. Brain tissue was immediately collected, cooled and sliced during neurosurgical operations to perform experiments on living tissue slices of the human brain. Among the blood degradation products, free iron (Fe2+ and Fe3+), but not hemoglobin, induced detrimental effects on pericyte function and survival (78.5% vs. 94.3%; p-value < 0.001). RNA sequencing revealed ferroptosis as the underlining cellular mechanism, mediated via GPX-4 (log2 fold change > 1.0, p-value < 1.08 × 10-30) in pathway analysis and eventually resulting in oxidative cell death. Pericytes located at cerebral capillary branching sites were specifically affected by ferroptosis, leading to capillary disruption and vasoconstriction, which were partially prevented by ferrostatin-1. Free iron induces the pericyte-dependent disruption of cerebral capillary function and represents a therapeutic target to attenuate secondary injury after intracerebral hemorrhage.
- Forums
- ASX - By Stock
- ATH
- Free iron in brain hemorrhage
ATH
alterity therapeutics limited
Add to My Watchlist
15.4%
!
1.5¢

Free iron in brain hemorrhage
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.5¢ |
Change
0.002(15.4%) |
Mkt cap ! $138.1M |
Open | High | Low | Value | Volume |
1.4¢ | 1.5¢ | 1.4¢ | $70.41K | 5.037M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 95000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 21150934 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70000 | 0.014 |
40 | 23014925 | 0.013 |
30 | 15509733 | 0.012 |
17 | 12434327 | 0.011 |
33 | 15163355 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 21150934 | 14 |
0.016 | 3096642 | 8 |
0.017 | 7321224 | 9 |
0.018 | 12443520 | 20 |
0.019 | 10047176 | 10 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |